Natural course of acquired vitelliform lesions associated with pigment epithelial detachments in dry age related macular degeneration

Eur J Ophthalmol. 2021 Nov;31(6):3133-3141. doi: 10.1177/1120672121990566. Epub 2021 Jan 28.

Abstract

Purpose: To describe the natural history of acquired vitelliform lesions (AVLs) associated with different types of pigment epithelial detachments (PEDs) in dry age-related macular degeneration.

Methods: A retrospective review of clinical examination and multimodal imaging data of patients with AVLs associated with PED(s) was performed.

Results: This study included 25 eyes of 17 patients. The mean age of patients was 67.2 ± 9.7 (47-83) years. The mean follow-up time was 32.6 ± 16.2 (12-66) months, excluding four patients (five eyes) that were lost to follow-up. The mean logMAR BCVA was 0.21 ± 0.16 at baseline and 0.38 ± 0.28 at final visit (p = 0.016). At the end of the follow-up period, PEDs enlarged in eight eyes (40%) and were unchanged in two eyes (10%). Spontaneous resolution of the central PED(s) with AVLs was seen in four (20%) eyes. Rupture of the PED(s) occurred in four eyes (20%), with two developing central foveolar atrophy afterwards. Overall, central foveolar atrophy was seen ultimately in four eyes (20%).

Conclusion: It seems that high PED size may be a risk factor for PED rupture during follow-up. 1/3 of the eyes ended up with unfavorable anatomical outcome.

Keywords: Age-related macular degeneration; retina – medical therapies; retinal pathology / research; techniques of retinal examination.

MeSH terms

  • Aged
  • Angiogenesis Inhibitors / therapeutic use
  • Fluorescein Angiography
  • Geographic Atrophy*
  • Humans
  • Intravitreal Injections
  • Middle Aged
  • Ranibizumab / therapeutic use
  • Retinal Detachment* / drug therapy
  • Retinal Pigment Epithelium
  • Retrospective Studies
  • Tomography, Optical Coherence
  • Visual Acuity

Substances

  • Angiogenesis Inhibitors
  • Ranibizumab